skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

PD-1/PD-L1 Inhibitors: The First Wave of Immuno-Oncology is a comprehensive look at the immuno-oncology landscape, and includes:

 

· An overview of the current immuno-oncology market

· Ongoing developments in the PD-1/PD-L1 therapy space

· Challenges with PD-1/PD-L1 inhibitor development and treatment

· An examination of:

o Non-small cell lung cancer (NSCLC)

o Bladder cancer

· A look at the future of immuno-oncology

 

Watch webinar recording here

 

Read also

;

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: